AR044801A1 - Sales de aminas del acido (2s)-2-etoxi-3-(4-{2-[hexil(2-feniletil)amino]-2-oxoetoxi}fenil)propanoico - Google Patents
Sales de aminas del acido (2s)-2-etoxi-3-(4-{2-[hexil(2-feniletil)amino]-2-oxoetoxi}fenil)propanoicoInfo
- Publication number
- AR044801A1 AR044801A1 ARP040102111A ARP040102111A AR044801A1 AR 044801 A1 AR044801 A1 AR 044801A1 AR P040102111 A ARP040102111 A AR P040102111A AR P040102111 A ARP040102111 A AR P040102111A AR 044801 A1 AR044801 A1 AR 044801A1
- Authority
- AR
- Argentina
- Prior art keywords
- phenylethyl
- amino
- phenyl
- ethoxy
- hexyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Un compuesto seleccionado entre uno o más de los siguientes: una sal (1R,2S)-2-hidroxiindan-1-amina de ácido (2S)-2-etoxi-3-(4-{2-[hexil(2-feniletil)amino]-2-oxoetoxi}fenil)propanoico; una sal de L-arginina de ácido (2S)-2-etoxi-3-(4-{2-[hexil(2-feniletil)amino-2-oxoetoxifenil)propanoico; una sal de tert-butilamina de ácido (2S)-2-etoxi-3-(4-{2-[hexil(2-feniletil)amino-2-oxoetoxifenil)propanoico; una sal de colina de ácido (2S)-2-etoxi-3-(4-{2-[hexil(2-feniletil)amino]-2-oxoetoxi}fenil)propanoico; una sal de adamantilamina de ácido (2S)-2-etoxi-3-(4-{2-[hexil(2-feniletil)amino]-2-oxoetoxi}fenil)propanoico; una sal de N-bencil2-feniletanaminio de ácido (2S)-2-etoxi-3-(4-{2-[hexil(2-feniletil)amino]-2-oxoetoxi}fenil)propanoico; una sal de N-bencil-2-(bencilamino)etanaminio de ácido (2S)-2-etoxi-3-(4-{2-[hexil(2-feniletil)amino]-2-oxoetoxi}fenil)propanoico; o una sal de tris(hidroximetil)metilamina de ácido (2S)-2-etoxi-3-(4-{2-[hexil(2-feniletil)amino]-2-oxoetoxi}fenil)propanoico. Sus solvato, hidrato, solvato/hidratomixto, forma no solvatada o no hidratada.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0314129.8A GB0314129D0 (en) | 2003-06-18 | 2003-06-18 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AR044801A1 true AR044801A1 (es) | 2005-10-05 |
Family
ID=27636788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040102111A AR044801A1 (es) | 2003-06-18 | 2004-06-17 | Sales de aminas del acido (2s)-2-etoxi-3-(4-{2-[hexil(2-feniletil)amino]-2-oxoetoxi}fenil)propanoico |
Country Status (23)
Country | Link |
---|---|
US (1) | US20060142389A1 (es) |
EP (1) | EP1638922A1 (es) |
JP (1) | JP3822900B1 (es) |
KR (1) | KR20060027348A (es) |
CN (1) | CN1809529A (es) |
AR (1) | AR044801A1 (es) |
AU (1) | AU2004247610B2 (es) |
BR (1) | BRPI0411525A (es) |
CA (1) | CA2528932A1 (es) |
CO (1) | CO5650228A2 (es) |
GB (1) | GB0314129D0 (es) |
IL (1) | IL172167A0 (es) |
IS (1) | IS8231A (es) |
MX (1) | MXPA05013714A (es) |
MY (1) | MY137277A (es) |
NO (1) | NO20055922L (es) |
RU (1) | RU2005138590A (es) |
SA (1) | SA04250169B1 (es) |
TW (1) | TW200503677A (es) |
UA (1) | UA81807C2 (es) |
UY (1) | UY28375A1 (es) |
WO (1) | WO2004110984A1 (es) |
ZA (1) | ZA200510252B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0314079D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
SE0104333D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
SE0104334D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
GB0229931D0 (en) * | 2002-12-21 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
PT1517883E (pt) | 2002-06-20 | 2008-04-21 | Astrazeneca Ab | Derivados do ácido benzóico substituído na posição orto para o tratamento de resistência à insulina |
SE0403072D0 (sv) * | 2004-12-16 | 2004-12-16 | Astrazeneca Ab | Pharmaceutically useful salts of carboxylic acid derivates |
WO2007004957A1 (en) * | 2005-07-05 | 2007-01-11 | Astrazeneca Ab | Novel crystalline form |
AR055073A1 (es) * | 2005-07-11 | 2007-08-01 | Astrazeneca Ab | Agentes terapeuticos |
JP2014522410A (ja) | 2011-06-06 | 2014-09-04 | アケビア セラピューティクス インコーポレイテッド | がん治療のための方法として低酸素誘導因子−2αを安定化するための、化合物および組成物 |
NO2686520T3 (es) | 2011-06-06 | 2018-03-17 | ||
DK3007695T3 (da) | 2013-06-13 | 2024-03-18 | Akebia Therapeutics Inc | Sammensætninger og fremgangsmåder til behandling af anæmi |
JP2016537365A (ja) | 2013-11-15 | 2016-12-01 | アケビア セラピューティクス インコーポレイテッドAkebia Therapeutics Inc. | {[5−(3−クロロフェニル)−3−ヒドロキシピリジン−2−カルボニル]アミノ}酢酸の固体形態、組成物、及びその使用 |
BR112017015852A2 (pt) | 2015-01-23 | 2018-03-27 | Akebia Therapeutics Inc | forma de cristal, sal hemicálcico, sal hemicálcico di-hidratado, sal monossódico hidratado, sal bissódico monoidratado, sal monossódico anidro e método para preparar o composto 1 |
HRP20211862T1 (hr) | 2015-04-01 | 2022-03-04 | Akebia Therapeutics, Inc. | Pripravci za i postupci liječenja anemije |
AR114886A1 (es) | 2018-05-09 | 2020-10-28 | Akebia Therapeutics Inc | Proceso para preparar ácido 2-[[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino]acético |
US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1208323C (zh) * | 1999-04-06 | 2005-06-29 | 三共株式会社 | α-取代羧酸衍生物 |
SE0104334D0 (sv) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
-
2003
- 2003-06-18 GB GBGB0314129.8A patent/GB0314129D0/en not_active Ceased
-
2004
- 2004-06-09 TW TW093116585A patent/TW200503677A/zh unknown
- 2004-06-16 RU RU2005138590/04A patent/RU2005138590A/ru not_active Application Discontinuation
- 2004-06-16 US US10/560,657 patent/US20060142389A1/en not_active Abandoned
- 2004-06-16 MX MXPA05013714A patent/MXPA05013714A/es not_active Application Discontinuation
- 2004-06-16 MY MYPI20042310A patent/MY137277A/en unknown
- 2004-06-16 CA CA002528932A patent/CA2528932A1/en not_active Abandoned
- 2004-06-16 SA SA04250169A patent/SA04250169B1/ar unknown
- 2004-06-16 CN CNA2004800169480A patent/CN1809529A/zh active Pending
- 2004-06-16 BR BRPI0411525-2A patent/BRPI0411525A/pt not_active IP Right Cessation
- 2004-06-16 UA UAA200511381A patent/UA81807C2/uk unknown
- 2004-06-16 AU AU2004247610A patent/AU2004247610B2/en not_active Expired - Fee Related
- 2004-06-16 EP EP04749009A patent/EP1638922A1/en not_active Withdrawn
- 2004-06-16 WO PCT/SE2004/000964 patent/WO2004110984A1/en active Application Filing
- 2004-06-16 KR KR1020057024204A patent/KR20060027348A/ko not_active Application Discontinuation
- 2004-06-16 JP JP2006517039A patent/JP3822900B1/ja not_active Expired - Fee Related
- 2004-06-17 AR ARP040102111A patent/AR044801A1/es not_active Application Discontinuation
- 2004-06-18 UY UY28375A patent/UY28375A1/es not_active Application Discontinuation
-
2005
- 2005-11-24 IL IL172167A patent/IL172167A0/en unknown
- 2005-12-13 NO NO20055922A patent/NO20055922L/no not_active Application Discontinuation
- 2005-12-15 ZA ZA200510252A patent/ZA200510252B/en unknown
- 2005-12-22 CO CO05129035A patent/CO5650228A2/es not_active Application Discontinuation
-
2006
- 2006-01-13 IS IS8231A patent/IS8231A/is unknown
Also Published As
Publication number | Publication date |
---|---|
JP3822900B1 (ja) | 2006-09-20 |
IL172167A0 (en) | 2009-02-11 |
SA04250169A (ar) | 2005-12-03 |
MY137277A (en) | 2009-01-30 |
IS8231A (is) | 2006-01-13 |
SA04250169B1 (ar) | 2007-08-07 |
NO20055922L (no) | 2006-01-06 |
MXPA05013714A (es) | 2006-06-27 |
JP2006527766A (ja) | 2006-12-07 |
KR20060027348A (ko) | 2006-03-27 |
WO2004110984A1 (en) | 2004-12-23 |
CA2528932A1 (en) | 2004-12-23 |
CN1809529A (zh) | 2006-07-26 |
UY28375A1 (es) | 2005-01-31 |
ZA200510252B (en) | 2006-12-27 |
EP1638922A1 (en) | 2006-03-29 |
US20060142389A1 (en) | 2006-06-29 |
AU2004247610A1 (en) | 2004-12-23 |
UA81807C2 (uk) | 2008-02-11 |
TW200503677A (en) | 2005-02-01 |
BRPI0411525A (pt) | 2006-08-01 |
RU2005138590A (ru) | 2006-07-27 |
CO5650228A2 (es) | 2006-06-30 |
GB0314129D0 (en) | 2003-07-23 |
AU2004247610B2 (en) | 2008-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR044801A1 (es) | Sales de aminas del acido (2s)-2-etoxi-3-(4-{2-[hexil(2-feniletil)amino]-2-oxoetoxi}fenil)propanoico | |
GT200500257AA (es) | Procedimiento para producir derivados de amina opticamente activos | |
ES2538364T3 (es) | Sales y polimorfos de un compuesto de tetraciclina | |
AR068479A1 (es) | (carboxilalquilenfenil) feniloxamidas, procedimiento para su preparacion y una coomposicion farmaceutica | |
CO2018005941A2 (es) | Formas sólidas de éster etílico del ácido (2r,4s)-5-(bifenil-4-il)-4-[(3-carboxipropionil)amino]-2-metil-pentanoico, sus sales y un método de preparación | |
RS54445B1 (en) | 3,5-DIAMINO-6-CHLORO-N- (N- (4- (4- (2- (HEXYL (2,3,4,5,6-PENTAHYDROXYHEXYL) AMINO) ETHOXY) PHENYL) BUTYL) CARBAMIMIDOIL) PYRAZINE -2-CARBOXAMIDE | |
AR042632A1 (es) | Compuestos derivados del acido (2s)-3-(4-{2-[amino]-2-oxoetoxi} fenil)-2-etoxipropanoico como agentes terapeuticos para trastornos en el metabolismo de los lipidos y composiciones farmaceuticas | |
CO6630136A2 (es) | Procedimiento para la preparación de 4-{4[({4-cloro-3-(trifluorometil) fenil]amino}carbonil)amino]-3-fluorofenoxi}-n-metilpiridina-2-carbocamida, sus sales y su monohidrato | |
EA201792052A1 (ru) | Соли амидов n-(1,3,4-оксадиазол-2-ил)арил карбоновой кислоты и их применение в качестве гербицидов | |
ATE540051T1 (de) | Age-inhibitoren | |
GT200300010A (es) | Esteres hidroxamato del acido n-(4-fenil sustituido)-antranilico | |
AR077080A1 (es) | Compuestos de 2,3-dihidro-1h-indeno | |
CL2018001067A1 (es) | Compuesto piranodipiridínico. | |
ES2524972T3 (es) | Método y sustancias para la preparación de compuestos de piridinio N-sustituidos | |
ES2634683T3 (es) | Método de preparación de cisteína o de un derivado de la misma utilizando una nueva O-fosfoserina sulfhidrilasa | |
AR104935A1 (es) | Formas cristalinas de un inhibidor de histona deacetilasa | |
AR053989A1 (es) | Compuestos espiro-hidantoina sustituidos con piridilo. composiciones farmaceuticas y procesos de obtencion. | |
UY27236A1 (es) | Inhibidores de pcp basados en ácidos 3-heterociclilpropanohidroxámicos | |
BR112012033030A2 (pt) | composição herbicida de sais de ácido picolínico | |
EA200600760A1 (ru) | Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их | |
NO20061302L (no) | Derivater av hydroksaminsyre som metalloproteinseinbitorer | |
CR20130158A (es) | Derivados de 1,4-oxazepina | |
AR055006A1 (es) | Sales farmaceuticamente utiles de derivados de acido carboxilico | |
AR044267A1 (es) | Compuesto intermedio util para la preparacion de pioglitazona | |
TH69682A (th) | สารบำบัด |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |